If a statin has left your muscles sore, stiff or weaker than they used to be, you are not alone in noticing it. Approximately 10% of people develop statin-associated muscle symptoms.[1] A study published in December 2025 in the Journal of Clinical Investigation points to one biological mechanism that may help explain why people with a rare mutation in a muscle calcium channel are especially sensitive to statin-related weakness. It was done in mice, so treat it as a clue, not a verdict. The study tested one rare RyR1 mutation in mice, so it does not by itself explain ordinary variation between people.[1]
What the researchers did
The team studied mice carrying a specific mutation in the ryanodine receptor type 1, known as RyR1. RyR1 is a calcium release channel in skeletal muscle, the muscle that moves your body. The mice received simvastatin, a common statin. The researchers also worked out, at the molecular level, where simvastatin attaches to the channel.[1]
The mouse doses are not directly comparable to a prescription for a person, so the numbers in this study cannot be carried over to your own dose.
What they found
- Mice carrying the RyR1 T4709M mutation developed simvastatin-induced muscle weakness.[1]
- A research drug from the Rycal class, which stabilizes the channel, prevented the simvastatin-induced weakness in these mice.[1]
- The authors write that people with RyR1 mutations “may represent a high-risk group for statin intolerance.”[1]
What this study does not show
- It does not show that the same thing happens in people. The mutation was tested in mice, and the authors frame the human risk as a possibility.
- It tested one statin, simvastatin. It says nothing direct about atorvastatin, rosuvastatin or other statins.
- It does not show that a statin caused the muscle aches in any given person. Many things cause muscle pain.
- The Rycal drug was a research tool in these mice. The study did not test it in people.
What to do with it
- Keep a short log. Write down the date you started or changed your statin dose, the muscle symptom, where you feel it, and how bad it is on a 0 to 10 scale. Bring the log to your clinician.
- Tell your clinician about muscle pain, weakness or dark urine, and ask how quickly they want to see you.
- If you have a known RYR1-related muscle condition, you may be in a higher-risk group for statin intolerance.[1] Tell the prescriber before you start a statin, and mention any close relative with a RYR1-related muscle condition.
- Do not start, stop or change a statin on your own. Ask whether a different statin, a lower dose or a non-statin option makes sense for your LDL cholesterol target.
References
[1] Weninger G, Dridi H, Reiken S, et al. Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation. Journal of Clinical Investigation, 2025;135(24):e194490. Published 15 December 2025. DOI: https://doi.org/10.1172/JCI194490. Population: mice (RyR1 T4709M-mutant), simvastatin exposure, in vivo and structural studies. Finding as used: approximately 10% of individuals develop statin-associated muscle symptoms (Introduction/abstract). RyR1 T4709M mice developed simvastatin-induced muscle weakness; a RyR1-stabilizing Rycal drug prevented the weakness in mice; the authors state that patients with RyR1 mutations may be a high-risk group for statin intolerance (a hypothesis, not tested in people). ↑︎ a b c d e f g

Kurt Greiner
Kurt is a digital strategist and IT professional blending emerging technology with practical application, exploring how individuals can leverage modern tools to navigate the second half of life with purpose.

Leave a Reply